Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Cefuroxime products are in shortage in Canada (3 of 13 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A cephalosporin antibiotic used to treat bacterial infections.
Products affected
3 / 13
In shortage since
Mar 31, 2020
Reports on file
29
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
CEFUROXIME FOR INJECTION, USP
750MG · POWDER FOR SOLUTION · STERIMAX INC
DIN 02422298 · since ?, no end estimate · BUSINESS REASONS.
Active shortage
CEFUROXIME FOR INJECTION, USP
7.5G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02422328 · since Jul 31, 2020, no end estimate · BUSINESS REASONS.
Active shortage
CEFUROXIME FOR INJECTION, USP
1.5G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02422301 · since Mar 31, 2020, no end estimate · BUSINESS REASONS
Resolved
CEFTIN
125MG · GRANULES FOR SUSPENSION · SANDOZ CANADA INCORPORATED
DIN 02212307 · ended May 25, 2026 · Disruption of the manufacture of the drug.
Resolved
CEFTIN
125MG · GRANULES FOR SUSPENSION · SANDOZ CANADA INCORPORATED
DIN 02212307 · ended Apr 27, 2026 · Disruption of the manufacture of the drug.
Resolved
CEFTIN
125MG · GRANULES FOR SUSPENSION · SANDOZ CANADA INCORPORATED
DIN 02212307 · ended Nov 28, 2025 · Demand increase for the drug.
Resolved
CEFUROXIME FOR INJECTION, USP
1.5G · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02241639 · ended Jul 10, 2025 · Delay in shipping of the drug.
Resolved
CEFTIN
125MG · GRANULES FOR SUSPENSION · SANDOZ CANADA INCORPORATED
DIN 02212307 · ended Oct 2, 2023 · Demand increase for the drug.
Resolved
CEFTIN
125MG · GRANULES FOR SUSPENSION · SANDOZ CANADA INCORPORATED
DIN 02212307 · ended Oct 2, 2023 · Demand increase for the drug.
Resolved
AURO-CEFUROXIME
250MG · TABLET · AURO PHARMA INC
DIN 02344823 · ended Jan 12, 2024 · Demand increase for the drug.
Resolved
APO-CEFUROXIME
250MG · TABLET · APOTEX INC
DIN 02244393 · ended Feb 8, 2023 · Disruption of the manufacture of the drug.
Resolved
CEFTIN
125MG · GRANULES FOR SUSPENSION · GLAXOSMITHKLINE INC
DIN 02212307 · ended Oct 28, 2022 · Demand increase for the drug.
Showing 12 of 29 reports. All reports are on file with Health Canada.
What's happening
Cefuroxime is currently affected by 3 active shortage reports filed with Health Canada by STERIMAX INC.
The reported causes are: business reasons; business reasons. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cefuroxime is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DC).
Recent changes
No changes recorded yet.
Common questions
What is Cefuroxime used for?
A cephalosporin antibiotic used to treat bacterial infections.
When will Cefuroxime be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Cefuroxime in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.